24 Nov
2020

US legislators move to close another “evergreening loophole” for orphan drugs

The US Congress is considering reform proposals targeting alleged abuses of rare disease treatment regulatory exclusivities

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth